The Cybersecurity and Infrastructure Security Agency is tracking an unknown malicious cyber actor who is spoofing the Small Business Administration COVID-19 loan relief webpage via phishing emails, the agency announced yesterday.

Sent to various recipients in the Federal Civilian Executive Branch and state, local, tribal and territorial government, the emails include a malicious link to the spoofed SBA website that the cyber actor is using for malicious re-directs and credential stealing, the agency said.

For details, including recommended mitigation actions and other resources, see the CISA alert.

“As we can see, heinous COVID-19-themed fraud schemes continue to perpetuate, and the common denominator seems to be enticing unsuspecting victims to provide funds, passwords or personal identifying information,” said John Riggi, AHA senior advisor for cybersecurity and risk. “To mitigate these threats, educate staff, always independently verify solicitations (even from ‘trusted’ sources), never provide down payments for PPE without verification and reputable references, and be suspect of any solicitations that claim to be affiliated with a government agency.’”

Related News Articles

Headline
Proactive COVID-19 testing of all long-term care staff and residents, who are usually at higher risk of contracting the virus, may help prevent potential…
Headline
The Food and Drug Administration yesterday approved a new drug application for propofol injectable emulsion, an intravenous general anesthetic and sedation…
Headline
In a sample of 598 hospitalized pregnant women with COVID-19, 55% had no symptoms on admission, according to a report released this week by the Centers for…
Headline
The Centers for Disease Control and Prevention today updated its testing guidance for SARS-CoV-2, the virus that causes COVID-19. “Due to the significance of…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response recently posted new and updated COVID-19 resources…
Headline
The Food and Drug Administration this week approved dexmedetomidine hydrochloride in 0.9% sodium chloride injection for the sedation of initially intubated and…